PML4 induces differentiation by Myc destabilization

Oncogene

Volumn 26, Issue 23, 2007, Pages 3415-3422

  Buschbeck, M ^a   Uribesalgo, I ^a   Ledl, A ^b   Gutierrez, A ^a   Minucci, S ^c   Muller, S ^b   Di Croce, L ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Cancer; Differentiation; Gene repression; Myc; Promyelocytic leukemia protein; Protein degradation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; ISOPROTEIN; MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P21;

ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE FUNCTION; GENE REPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TUMOR SUPPRESSOR GENE;

CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VITAMIN D;

EID: 34249005636     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210128     Document Type: Article

References (29)

1. Adhikary S, Eilers M. (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645.
2. Amati B. (2004). Myc degradation: dancing with ubiquitin ligases. Proc Natl Acad Sci USA 101: 8843-8844.
3. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K et al. (1995). The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14: 1532-1541.
4. Buschbeck M, Hofbauer S, Croce LD, Keri G, Ullrich A. (2005). Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival. EMBO Rep 6: 63-69.
5. Cairo S, De Falco F, Pizzo M, Salomoni P, Pandolfi PP, Meroni G. (2005). PML interacts with Myc and Myc target gene expression is altered in PML-null fibroblasts. Oncogene 24: 2195-2203.
6. Di Croce L. (2005). Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet 14 (Spec No. 1): R77-R84.
7. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. (2002). Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
8. Eisenman RN. (2001). Deconstructing myc. Genes Dev 15: 2023-2030.
9. Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D et al. (1998). Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16: 2905-2913.
10. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. (2001). Binding of c-Myc to chromatin mediates mitogeninduced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
11. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. (1997). Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 89: 376-387.
12. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V et al. (1997). Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 94: 5302-5307.
13. Herbst A, Salghetti SE, Kim SY, Tansey WP. (2004). Multiple cell-type-specific elements regulate Myc protein stability. Oncogene 23: 3863-3871.
14. Jensen K, Shiels C, Freemont PS. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223-7233.
15. Kalejta RF, Shenk T. (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 100: 3263-3268.
16. Kanatani Y, Kasukabe T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Nagata N, Motoyoshi K et al. (1999). Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1. Cell Growth Differ 10: 705-712.
17. Lafarga M, Berciano MT, Pena E, Mayo I, Castano JG, Bohmann D et al. (2002). Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin and protein substrates of proteasome. Mol Biol Cell 13: 2771-2782.
18. Melnick A, Licht JD. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215.
19. Nilsson JA, Cleveland JL. (2003). Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007-9021.
20. Rockel TD, Stuhlmann D, von Mikecz A. (2005). Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci 118: 5231-5242.
21. Salghetti SE, Kim SY, Tansey WP. (1999). Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18: 717-726.
22. Salomoni P, Pandolfi PP. (2002). The role of PML in tumor suppression. Cell 108: 165-170.
23. Seoane J, Le HV, Massague J. (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
24. Smith KP, Byron M, O'Connell BC, Tam R, Schorl C, Guney I et al. (2004). c-Myc localization within the nucleus: evidence for association with the PML nuclear body. J Cell Biochem 93: 1282-1296.
25. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H et al. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3: 392-399.
26. Strudwick S, Borden KL. (2002). Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities. Leukemia 16: 1906-1917.
27. Treier M, Staszewski LM, Bohmann D. (1994). Ubiquitindependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798.
28. Villa R, Morey L, Raker VA, Buschbeck M, Gutierrez A, De Santis F et al. (2006). The methyl-CpG binding protein MBD1 is required for PML-RARalpha function. Proc Natl Acad Sci USA 103: 1400-1405.
29. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V et al. (2003). Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351-360.